Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Reynolds

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Clinical Biochemist. Reviews|December 17, 2009
The ethics of antenatal screening: lessons from CanuteTimothy M Reynolds
Current Opinion in Cardiology|June 7, 2019
Genetic risk scores in lipid disordersAnthony S Wierzbicki, Timothy M Reynolds
International Journal of Clinical Practice|September 28, 2019
Computational models and neural nets: Fantastic models-Where to find them and how to identify themAnthony S Wierzbicki, Timothy M Reynolds
International Journal of Clinical Practice|January 12, 2019
Primum non nocere: Demand management in pathology and preventing harmAnthony S Wierzbicki, Timothy M Reynolds
Current Medical Research and Opinion|April 12, 2013
Secondary tests for stratification of risk for atherosclerosisAnthony S Wierzbicki, Timothy M Reynolds
The Breast Journal|February 1, 2003
Does evidence-based medicine provide evidence? The evidence on breast cancer and the safety of oral contraceptives suggests that unorthodox interpretations may be just as validTimothy M Reynolds, Anthony S Wierzbicki
Annals of Clinical Biochemistry|September 1, 2007
Can we manage demand for allergy testing by restricting requests to a small number of prime target allergens?Timothy M Reynolds, Patrick J Twomey
Journal of Clinical Pathology|September 1, 2007
Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classificationTimothy M Reynolds, Patrick J Twomey
Annals of Clinical Biochemistry|January 5, 2006
Prevalence of kidney disease and estimated GFR in routine practiceTimothy M Reynolds, Patrick J Twomey
Lancet (London, England)|April 6, 2004
Cost utility of prenatal diagnosisAnthony S Wierzbicki, Timothy M Reynolds
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Clinical Biochemist. Reviews|December 17, 2009
The ethics of antenatal screening: lessons from CanuteTimothy M Reynolds
Current Opinion in Cardiology|June 7, 2019
Genetic risk scores in lipid disordersAnthony S Wierzbicki, Timothy M Reynolds
International Journal of Clinical Practice|September 28, 2019
Computational models and neural nets: Fantastic models-Where to find them and how to identify themAnthony S Wierzbicki, Timothy M Reynolds
International Journal of Clinical Practice|January 12, 2019
Primum non nocere: Demand management in pathology and preventing harmAnthony S Wierzbicki, Timothy M Reynolds
Current Medical Research and Opinion|April 12, 2013
Secondary tests for stratification of risk for atherosclerosisAnthony S Wierzbicki, Timothy M Reynolds
The Breast Journal|February 1, 2003
Does evidence-based medicine provide evidence? The evidence on breast cancer and the safety of oral contraceptives suggests that unorthodox interpretations may be just as validTimothy M Reynolds, Anthony S Wierzbicki
Annals of Clinical Biochemistry|September 1, 2007
Can we manage demand for allergy testing by restricting requests to a small number of prime target allergens?Timothy M Reynolds, Patrick J Twomey
Journal of Clinical Pathology|September 1, 2007
Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classificationTimothy M Reynolds, Patrick J Twomey
Annals of Clinical Biochemistry|January 5, 2006
Prevalence of kidney disease and estimated GFR in routine practiceTimothy M Reynolds, Patrick J Twomey
Lancet (London, England)|April 6, 2004
Cost utility of prenatal diagnosisAnthony S Wierzbicki, Timothy M Reynolds
Pageof 4